- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Pfizer Limited has received a tax demand order totaling ₹29.49 crore from the Central GST Division for alleged short payment of taxes and excess Input Tax Credit for the period from July 2017 to March 2021. The breakdown includes a tax demand of ₹14.39 crore, interest of ₹0.05 crore, and a penalty of ₹14.64 crore. The company plans to appeal against this order, asserting that the demand is not maintainable and emphasizing that it expects no material impact on its financial performance or operations. This situation may present a neutral impact for investors, but it reinforces the need to monitor regulatory compliance closely.